Topic: Andrew Witty
Local Heroes WHAT the Cabinet Office called “local heroes” included GlaxoSmithKline chief executive Andrew Witty. His knighthood will have helped...
LONDON (Reuters) - GlaxoSmithKline Plc has agreed in principle to settle several long-standing disputes with the U.S. government over the way it marketed and developed drugs, at a cost of $3 billion, which is covered by existing provisions.Settlement of the civil ...
SEATTLE/LONDON (Reuters) -An experimental vaccine from GlaxoSmithKline halved the risk of African children getting malaria in a major clinical trial, making it likely to become the world's first shot against the deadly disease.Final-stage trial data released on Tuesday showed ...
Research and development expenditures in the biotech industry fell in 2010 for the second straight year. But Big Pharma's increasing reliance on...
(Reuters) - At least three private equity firms are planning to bid for a clutch of GlaxoSmithKline's non-prescription products, expecting limited competition from rival large pharma groups, people familiar with the process said.Advent International, Cinven and Warburg Pincus are among firms ...
GlaxoSmithKline PLC (GSK. LN) Tuesday is expected to report that sales in the second quarter fell again, but at a slower rate than in previous...
British drugmaker GlaxoSmithKline said on Wednesday that net profit rose 14 percent to £1.525 billion (1.72 billion euros, $2.5 billion) in the first quarter, despite a slump in product sales.Savings from a major cost-cutting programme and asset disposals ...
LONDON (Reuters) - Joe Cohen, a scientist tantalizingly close to delivering the world's first malaria vaccine, is on the stump.After 23 years of painstaking laboratory work and a program of major trials in seven countries, the 67-year-old biologist says the clinical ...
GlaxoSmithKline PLC (GSK) Monday welcomed news the U.K. government will cut the rate of corporation tax on income from patents--the life-blood of...
LONDON (Reuters) - Drugmaker GlaxoSmithKline insisted there would be no change to its cautious stance on deal-making, after announcing it had hired one of Europe's top M&A bankers as its new finance chief.Goldman Sachs investment banker Simon Dingemans, 47, will ...
Photo Gallery
Video Gallery
-
GSK: Q1 results 2011 - CEO Andrew ...
GSK CEO, Andrew Witty outlines GSK's Q1 2011 results ...2011-04-27 -
GSK: Andrew Witty in Africa
Following the groundbreaking commitments GlaxoSmithKline (GSK) made to improve access ...2009-07-30 -
GSK: CEO Andrew Witty discusses collaboration ...
GlaxoSmithKline welcomes the European Commission's commitment to promote collaborative ...2011-11-17
